Comprehensive analysis of karyotypic mosaicism between trophectoderm and inner cell mass by Johnson, D.S. et al.
ORIGINAL RESEARCH
Comprehensive analysis of karyotypic
mosaicism between trophectoderm
and inner cell mass
D.S. Johnson1,4,*, C. Cinnioglu1, R. Ross2, A. Filby3, G. Gemelos1,
M. Hill1,A .R y a n 1, D. Smotrich2, M. Rabinowitz1, and M.J. Murray3
1Gene Security Network, Inc., 2686 Middleﬁeld Road, Suite C, Redwood City, CA 94063, USA
2La Jolla IVF, 9850 Genesee Avenue #610, La
Jolla, CA 92037, USA
3Northern California Fertility Medical Center, 1130 Conroy Lane, Suite 100, Roseville, CA 95661, USA
4Present address: GigaGen Inc., 409 Illinois St, San Francisco, CA 94158, USA
*Correspondence address. E-mail: seasquirtdoctor@gmail.com
Submitted on March 23, 2010; resubmitted on July 6, 2010; accepted on July 12, 2010
abstract: Aneuploidy has been well-documented in blastocyst embryos, but prior studies have been limited in scale and/or lack
mechanistic data. We previously reported preclinical validation of microarray 24-chromosome preimplantation genetic screening in a 24-
h protocol. The method diagnoses chromosome copy number, structural chromosome aberrations, parental source of aneuploidy and dis-
tinguishes certain meiotic from mitotic errors. In this study, our objective was to examine aneuploidy in human blastocysts and determine
correspondence of karyotypes between trophectoderm (TE) and inner cell mass (ICM). We disaggregated 51 blastocysts from 17 couples
into ICM and one or two TE fractions. The average maternal age was 31. Next, we ran 24-chromosome microarray molecular karyotyping
on all of the samples, and then performed a retrospective analysis of the data. The average per-chromosome conﬁdence was 99.95%.
Approximately 80% of blastocysts were euploid. The majority of aneuploid embryos were simple aneuploid, i.e. one or two whole-chromo-
some imbalances. Structural chromosome aberrations, which are common in cleavage stage embryos, occurred in only three blastocysts
(5.8%). All TE biopsies derived from the same embryos were concordant. Forty-nine of 51 (96.1%) ICM samples were concordant with
TE biopsies derived from the same embryos. Discordance between TE and ICM occurred only in the two embryos with structural chromo-
some aberration. We conclude that TE karyotype is an excellent predictor of ICM karyotype. Discordance between TE and ICM occurred
only in embryos with structural chromosome aberrations.
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Introduction
Chromosome imbalances are well-documented in early stage human
embryos cultured during in vitro fertilization (IVF) (Munne ´ et al.,
1995, 2007; Wells and Delhanty, 2000; Voullaire et al., 2000; Baart
et al., 2004, 2007; Vanneste et al., 2009; Johnson et al., 2010). Clini-
cally, chromosome imbalances are diagnosed using preimplantation
genetic screening (PGS) on three types of biopsies: (i) polar bodies,
(ii) cleavage stage blastomeres and (iii) trophectoderm (TE) biopsies.
Each type of biopsy has advantages and disadvantages.
Polar body biopsies only detect maternal meiotic chromosome
imbalances and for comprehensiveness, both polar bodies I and II
should be evaluated. Many embryos that extrude polar bodies do
not reach blastoscyst stage, wasting effort to analyze embryos that
arrest early in development.
Blastomere biopsy is generally considered the least technically chal-
lenging and is currently the most common type of biopsy for PGS. In
contrast to polar body biopsies, blastomere biopsies enable the ana-
lyses of both meiotic and mitotic whole-chromosome imbalances.
However, blastomere biopsy has limitations because up to 60% of
embryos at cleavage stage exhibit mosaicism, where at least one cell
has a different ploidy state from the other cells in the embryo
(Vanneste et al., 2009; Johnson et al., 2010). Additionally, many clea-
vage stage embryos diagnosed as aneuploid with blastomere biopsy
will ‘self-correct’ by blastocyst stage, which, from a clinical stand
point, may decrease the chances of a live birth by prematurely labeling
an embryo as abnormal (Baart et al., 2004, 2007; Li et al., 2005;
Munne ´ et al., 2005; Barbash-Hazan et al., 2008; Frumkin et al.,
2008). Although blastomere biopsies often successfully predict
ploidy of the fetus, limitations such as mosaicism and self-correction
complicate a correct diagnosis, even when using highly accurate PGS
technologies.
TE biopsies from Day 5 blastocysts are an increasingly attractive and
prevalent alternative to polar bodies and blastomere biopsies because
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and are only performed on high-quality blastocysts that have had the
opportunity to ‘self-correct’, improving laboratory efﬁciency.
However, comparisons of aneuploidy rates with blastomere biopsies
versus TE biopsies are conﬂicting. Whereas studies using ﬂuorescence
in situ hybridization (FISH) have found similar rates of aneuploidy in
cleavage stage and TE measurements (Sandalinas et al., 2001; Bie-
lanska et al., 2002, 2005; Baart et al., 2004, 2007; Coonen et al.,
2004; Munne ´ et al., 2005; Daphnis et al., 2008), studies using
G-band analysis or comparative genome hybridization (CGH) found
low rates of aneuploidy in blastocysts compared with cleavage stage
measurements (Clouston et al., 1997, 2002; Voullaire et al., 2002; Fra-
gouli et al., 2008, 2009; Schoolcraft et al., 2009; Sher et al., 2009).
Mosaicism occurs in blastocysts, but apparently at lower levels than
in cleavage stage embryos. Prior work using FISH has suggested high
rates of mosaicism within TE biopsies (Bielanska et al., 2002, 2005;
Derhaag et al., 2003; Baart et al., 2006), whereas G-banding has
suggested low rates of mosaicism (Clouston et al., 1997, 2002). Mosai-
cism between the TE and the inner cell mass (ICM) might lead to
so-called ‘conﬁned placental mosaicism’, wherein the placenta is
mosaic aneuploid and the fetus is euploid (Kalousek and Dill, 1983).
However, data comparing mosaicism between the TE and ICM are
very limited. One small study of 10 embryos with CGH showed
100% concordance between TE and ICM (Fragouli et al., 2008). To
date, large and comprehensive studies of concordance between TE
and ICM in high-quality embryos have not been performed using
24-chromosome screening. Currently such studies are highly relevant,
as reports of clinical application of PGS with TE biopsies have been
increasing in number (Veeck et al., 2004; MacArthur et al., 2005;
Kokkali et al., 2007; MacArthur et al., 2008; Fragouli et al., 2009;
Schoolcraft et al., 2009; Sher et al., 2009).
In the current study, our primary goals were (i) to examine the
extent and mechanism of aneuploidy in a large cohort of high-quality
blastocyst stage embryos and (ii) investigate the rate of mosaicism
between the TE and ICM. To this end, we obtained 51 fresh and
frozen blastocysts, and disaggregated them into TE and ICM fractions.
We then performed 24-chromosome microarray molecular karyotyp-
ing using a previously developed technique that makes use of parental
and embryo data to diagnose whole-chromosome imbalances, struc-
tural chromosome aberrations and parental source of aneuploidy,
and to determine whether certain errors resulting in additional
chromosomes are mitotic or meiotic in origin (Johnson et al., 2010).
This study was to designed to investigate whether TE biopsies are
representative of chromosomal status of the ICM, a question of high
relevance to their application to PGS.
Materials and Methods
Embryo culture and disaggregation
Informed consent was obtained from patients under a protocol reviewed
and approved by an Institutional Review Board. Embryos were obtained
from 17 couples (Supplementary Table SI). The maternal age averaged
across all blastocysts in the cohort was 31. The youngest mother was
22 and the oldest was 37. Embryos were graded (1 ¼ best; 4 ¼ worst)
according to a modiﬁcation of a previously published scoring system
(Schoolcraft et al., 1999). Embryos graded 1 had an ICM that was tightly
packed with many cells, and a TE with many cells forming a cohesive
epithelium; embryos graded as 2 had an ICM that was loosely grouped
with many cells, and a TE with a few cells forming a loose epithelium;
embryos graded as 3 had an ICM that was loosely grouped with several
cells and a TE with a few cells forming a loose epithelium; and embryos
graded as 4 had an ICM with very few cells and a TE with very few
large cells. The average embryo grade was 1.65, and 87.8% of embryos
were either hatching or expanding blastocysts.
IVF stimulation protocols were individualized based on the patient’s age,
determination of ovarian reserve and response to prior therapies, when
available. All patients received injectable follicle stimulating hormone
(FSH) or a combination of human chorionic gonadotrophin (hCG) and
FSH with either a gonadotrophin releasing hormone agonist or antagonist.
Oocytes were obtained by transvaginal guided follicle aspiration 36 h after
administration of hCG. Fertilization was performed by either overnight
co-incubation of oocytes with spermatozoa or intracytoplasmic sperm
injection ( 40 h after hCG), depending on clinical indications and
semen parameters. Sage commercial sequential media were used for fer-
tilization and embryo culture: Quinn’s Advantage Fertilization Medium
supplemented with 10% serum protein substitute (SPS), Quinn’s Advan-
tage Cleavage Medium supplemented with 10% SPS and Quinn’s Advan-
tage Blastocyst Medium supplemented with 20% SPS (CooperSurgical).
The majority of the embryos (37 of 51) were cryopreserved at Day 5
using Quinn’s Advantage Blastocyst Freeze Kit (CooperSurgical). These
embryos were thawed using Quinn’s Advantage Blastocyst Thaw Kit
(CooperSurgical) and then cultured in Sage Blastocyst Media for 18 h.
Full expansion, lack of fragmentation and deﬁnable ICM were criteria for
inclusion in this study (Supplementary Figs S1–III). A minority of the
embryos (14 of 51) were disaggregated at Day 5 without cryopreservation.
These 14 embryos were of high morphological quality, but were not cryo-
preserved because cleavage stage PGS for these embryos yielded no
results, indicated aneuploidy or indicated a gender other than that which
was desired by the patients.
Blastocysts were manually removed from zona pellucida and extraneous
cells were separated from the embryo to exclude fragmented material. TE
was separated from ICM using a mechanical blade (Ultra Sharp Splitting
Blades, Bioniche Animal Health, WA, USA) attached to a micromanipula-
tor (Fragouli et al., 2008). Visual identiﬁcation of ICM was essential for
inclusion in the study, even though with visual identiﬁcation it is possible
that TE cells would occasionally contaminate the ICM fraction. When
possible, TE was mechanically separated into two fractions. Fractions
were washed sequentially four times using a stripper tip in 10 ml drops
of washing buffer (Johnson et al., 2010). Following the ﬁnal washing
drop, fractions were placed in a 0.2 ml microcentrifuge tube containing
5 ml of washing buffer. The tubes were then frozen on dry ice.
Lysis, ampliﬁcation and genotyping of
blastomeres and parental samples
We thawed all fractions at 228C, and then added Arcturus PicoPure Lysis
Buffer (Molecular Devices, Sunnyvale, CA, USA) to each of the biopsies.
The tubes were incubated at 568C for 1 h, and then heat-inactivated at
958C for 10 min. DNA from the lysed biospsies was ampliﬁed using a
commercial kit (GE Healthcare, Waukesha, WI, USA) for multiple displa-
cement ampliﬁcation (MDA). MDA reactions were incubated at 308C for
2.5 h and then heat-inactivated at 658C for 5 min. The ampliﬁed samples
were genotyped using Illumina (San Diego, CA, USA) Inﬁnium II genotyp-
ing microarrays (CytoSNP-12 chips) using a modiﬁed 24-h protocol, as
described previously (Johnson et al., 2010).
Parent Buccal samples were collected using MasterAmp Buccal Swabs
(Madison, WI, USA). Genomic DNA was isolated from these swabs
using Epicentre DNA Extraction solution (Madison, WI, USA). For par-
ental samples, the standard Inﬁnium II protocol (www.illumina.com) was
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Biotechnology Information (www.ncbi.nlm.nih.gov/geo/) under accession
identiﬁer GSE22864.
Determination of chromosome imbalances
Previously, we developed a genotyping microarray molecular karyotyping
technology that uses parental genetic data to increase accuracy and deter-
mine mechanism and source of aneuploidy (Johnson et al., 2010). The
algorithm uses parental genotypes and the observed distribution of unpro-
cessed single cell microarray channel intensities to diagnose whole-
chromosome imbalances and structural chromosome aberrations
(Johnson et al., 2010). Because parental genotypes are available, the algor-
ithm readily identiﬁes parental source of whole-chromosome imbalances
and structural chromosome aberrations. Additionally, the algorithm uses
parental information, high-conﬁdence disomic single cell measurements
on children, and recombination probabilities (genome.ucsc.edu) to deter-
mine the phase of the parental chromosomes. The phased data are then
used to determine whether certain trisomies and uniparental disomies
were mitotic or meiotic in origin (Johnson et al., 2010).
Results
Prevalence of aneuploidy is signiﬁcantly
lower in blastocysts than in cleavage stage
embryos
We isolated 51 ICM samples and 80 matching TE samples from 51
blastocyst embryos. For 29 of the embryos (59.9%), we were able
to separate the TE into two distinct fractions. We then applied
24-chromosome microarray molecular karyotyping technology to
each fraction. The algorithm assigns each chromosome a conﬁdence
level, i.e. a numerical estimate of data quality. Conﬁdence is calculated
per-chromosome, not per-sample, because each chromosome is
modeled independently. The average conﬁdence in the chromosome
calls was 99.95%, and 99.2% of chromosomes were called above 99%
conﬁdence. Prior work using the same microarray technology indi-
cated that conﬁdences are strongly correlated with accuracy
(Johnson et al., 2010). Thus, we conclude that the exceptionally high-
conﬁdences in the current data set indicate a particularly high-quality
set of molecular karyotypes. The molecular karyotype data also
enabled analysis of rates of aneuploidy, mechanism of aneuploidy
(mitotic versus meiotic), parental source of aneuploidy and structural
chromosome aberrations in the blastocyst fractions (Table I and Sup-
plementary Table SII).
Overall, per-sample rates of euploidy were high, with 82.5 and
80.4% euploidy rates for the TE and ICM, respectively (Table I and
Supplementary Table SII). Among aneuploid samples, the majority
were simple aneuploid, i.e. only one or two non-disomic chromo-
somes (75.0% for TE and 70.0% for ICM). One of the two complex
aneuploid embryos (4–149) had three meiotic whole-chromosome
imbalances in each of the three fractions, and the second embryo
(2–255) was diagnosed as maternal haploid across all three fractions.
There was no relationship between reason for infertility and aneu-
ploidy (Supplementary Table SI). The grade of aneuploid embryos
was 1.7, which was no worse than euploid embryos (t-test, P . 0.05).
Next, we examined the types of aneuploidy that occurred in the
blastocysts. Monosomies accounted for the majority of non-disomic
chromosomes, but were not signiﬁcantly more common than
trisomies (x
2, P . 0.05). Among monosomies, paternal source was
not signiﬁcantly more common than maternal source (x
2, P . 0.05).
Meiotic trisomies were the most common trisomies when evaluated
per-sample (100% among TE and 75.0% among ICM fractions), but
this trend was also not signiﬁcant (x
2, P . 0.05). Paternal monosomies
(i.e. the maternal chromosome was missing) were signiﬁcantly more
common than maternal monosomies (x
2, P ¼ 0.002). There was no
relationship between the reason for infertility and type of aneuploidy.
In fact, egg donors suffered as much meiotic aneuploidy as women
with other reasons for infertility (Supplementary Table SI).
Low prevalence of mosaicism between TE
and ICM
We next examined rates of mosaicism between ICM and TE, as well
as between TE fractions, when such comparisons were possible
(Tables II and III; Supplementary Table SII). Only two embryos
(3.9%) were mosaic between ICM and TE. None of the 30 matched
TE fractions were discordant. Prior work using the same DNA micro-
array technology indicated a 57.7% rate of mosaicism in a cohort of
cleavage stage embryos, signiﬁcantly higher than the rate of mosaicism
between the TE and ICM in the current cohort of blastocysts
(x
2, P , 0.01; Johnson et al., 2010).
We also examined whether parental source of aneuploidy or
meiotic/mitotic whole-chromosome imbalances were associated
with mosaicism. We did not observe mosaicism in any of the three
embryos with putative whole-chromosome meiotic errors. The
maternal haploid embryo was also not mosaic. None of the maternal
or paternal whole-chromosome monosomies were mosaic. The
one embryo that was mosaic for a whole-chromosome imbalance
(7–249) was discordant between the TE and ICM for a paternal
mitotic trisomy on Chromosome 13. Although our sample size is
small, we speculate that mosaicism may result from mitotic whole-
chromosome imbalances rather than meiotic whole-chromosome
imbalances.
........................................................................................
Table I Per fraction microarray results.
TE ICM
Number of biopsies 80 51
Number of embryos 51 51
Euploid 66 (82.5%) 41 (80.4%)
Simple aneuploid 12 (15.0%) 7 (15.7%)
Complex aneuploid 4 (3.8%) 3 (5.9%)
Maternal monosomy 6 (7.5%) 4 (7.8%)
Paternal monosomy 3 (3.8%) 3 (5.9%)
Maternal trisomy 4 (5.0%) 2 (3.9%)
Paternal trisomy 2 (2.5%) 2 (3.9%)
Maternal meiotic trisomy 4 (5.0%) 2 (3.9%)
Paternal meiotic trisomy 2 (2.5%) 1 (1.9%)
Maternal haploid 1 (1.3%) 1 (1.9%)
Structural chromosome aberrations 2 (2.5%) 3 (5.8%)
No result 0 (0.0%) 0 (0.0%)
Aneuploidy rates classiﬁed by mechanism and parental source of aneuploidy, computed
per biopsy and segregated into TE and ICM biopsies.
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Next, we examined structural chromosome aberrations among the
blastocyst fractions (Supplementary Table SII). Only three embryos
and three chromosomes were diagnosed with structural chromosome
aberrations.Twoembryosfromoneofthefamilies(7–249and 9–249)
revealed structural chromosome aberrations on two separate
embryos on Chromosome 12. The diagnosis was consistent
between TE and ICM fractions in each of these two embryos. One
of the embryos was missing 12:q14.2-qter from the maternal copy
and the other embryo was missing 12:q14.2-qter from the paternal
copy. Additionally, both of these structural chromosome aberrations
are associated with mitotic malsegregation of other chromosomes in
the same embryo. This patient was undergoing IVF due to endome-
triosis. The third embryo with a structural chromosome imbalance
(2–252) showed deletion of maternal 16:p11.2-qter combined with
a meiotic duplication of maternal 16:p11.2-pter, but only in the ICM
fraction. Chromosome 16 was missing the full maternal copy in
both TE fractions from this embryo. This patient was infertile due to
tubal disease.
Discussion
We have performed the largest-ever reported study of mosaicism
between the ICM and TE in blastocyst stage human IVF embryos
using 24-chromosome microarray screening. We found signiﬁcantly
higher rates of euploidy in blastocysts than we have seen previously
in cleavage stage embryos (Johnson et al., 2010). Several large
studies of blastocysts using FISH, G-band analysis or CGH reported
aneuploidy rates between 32 and 77.4% (Evsikov and Verlinsky,
1998; Magli et al., 2000; Clouston et al., 2002; Voullaire et al., 2002;
Derhaag et al., 2003; Fragouli et al., 2008, 2009; Schoolcraft et al.,
2009; Sher et al., 2009). Our cohort of embryos had an average
maternal age of 31, younger than prior studies (Evsikov and Verlinsky,
1998; Clouston et al., 2002; Voullaire et al., 2002; Derhaag et al.,
2003; Fragouli et al., 2008, 2009; Schoolcraft et al., 2009), which prob-
ably accounted for the relatively higher rate of euploidy. Presumably,
the lower rate of aneuploidy by blastocyst stage is due to selective
arrest by Day 5 of embryos diagnosed as aneuploid at cleavage
stage (Fragouli et al., 2008).
Generally, because aneuploidy rates were so low in this cohort of
blastocysts, we were not able to ﬁnd any statistically signiﬁcant
.............................................................................................................................................................................................
Table II Mosaicism in aneuploid embryos.
Embryo Maternal
age
Family ICM TE-1 TE-2 Mosaic
2–252 37 252 45XY, 216(mat)(struct)(mei) 45XY, 216(mat) 45XY, 216(mat) Yes
4–253 29 253 45XX, 214(mat) 45XX, 214(mat) 45XX, 214(mat) No
6–149 28 149 45XY, 216(mat) 45XY, 216(mat) No
9–249 31 249 45XY, 212(mat)(struct) 45XY, 212(mat)(struct) No
2–148 22 148 45X, 2X(pat) 45X, 2X(pat) No
2–255 34 255 23X, 21, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11,
12, 13, 14, 15, 16, 17, 18, 19, 20, 21,
22, sex(pat)
23X, 21, 2, 3, 4, 5, 6, 7, 8, 9, 10,
11, 12, 13, 14, 15, 16, 17, 18, 19,
20, 21, 22, sex(pat)
23X, 21, 2, 3, 4, 5, 6, 7, 8, 9,
10, 11, 12, 13, 14, 15, 16, 17,
18, 19, 20, 21, 22, sex(pat)
No
7–249 31 249 46XY, 212(pat)(struct),
+13(pat)mit
45XY, 212(pat)(struct) Yes
3–252 37 252 47XXY, +sex(pat)mei 47XXY, +sex(pat)mei 47XXY, +sex(pat)mei No
4–149 28 149 49XX, +3(mat)mei, +6(mat)mei,
+19(mat)mei
49XX, +3(mat)mei,
+6(mat)mei, +19(mat)mei
49XX, +3(mat)mei,
+6(mat)mei, +19(mat)mei
No
4–249 31 249 47XY, +15(mat)mei 47XY, +15(mat)mei 47XY, +15(mat)mei No
Concordance between ICM and TE fractions for the 10 aneuploid embryos. Karyotypes are indicated with standard nomenclature, except ‘mat’ indicates maternal source, ‘pat’ indicates
paternal source, ‘mei’ indicates meiotic mechanism, ‘mit’ indicates mitotic mechanism and ‘struct’ indicates a structural chromosome aberration. The ‘Mosaic’ column indicates whether
any one chromosome differed between any pair of biopsies from the same embryo.
.............................................................................................................................................................................................
Table III Structural chromosome aberrations.
Embryo Maternal age Family ICM TE-1 TE-2 Mosaic?
2–252 37 252 216:p11.2-qter (mat), +16:p11.2-pter (mat)(mei) ND ND Yes
7–249 31 253 212:q14.2-qter (mat) 212:q14.2-qter (mat) NA No
9–249 31 149 212:q14.2-qter (pat) 212:q14.2-qter (pat) NA No
Summary of speciﬁc karyotype for the three embryos that suffered structural chromosome aberrations. In the karyotype annotation, ‘mat’ indicates maternal source, ‘pat’ indicates
paternal source and ‘mei’ indicates meiotic mechanism. ‘ND’ indicates that no structural chromosome aberration was detected and ‘NA’ indicates that no measurement was made. The
‘Mosaic’ column indicates whether any one chromosome differed between any pair of biopsies from the same embryo.
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blastocyst stage. However, we saw a low rate of complex aneuploidy
by the blastocyst stage, suggesting that most embryos that suffer from
severe complex aneuploidy at cleavage stage will not form blastula.
Although the trend was not statistically signiﬁcant, 9 of 10 reported
trisomies were meiotic in origin, suggesting that meiotic mechanisms
predominate among aneuploid blastocysts. Chromosome 16 aneu-
ploidy occurred in 3 of 10 of the aneuploid embryos, and was thus
the most frequently aneuploid chromosome. The propensity of
Chromosome 16 to suffer whole-chromosome imbalance has been
previously reported in cleavage stage embryos (Munne ´ et al., 1995;
Munne ´ et al., 2007), blastocysts (Clouston et al., 1997, 2002) and
pregnancy wastage (Simpson 2007). One of the embryos completely
lacked the paternal genetic complement. This phenomenon has
been reported once previously in a series of 91 blastocysts (Evsikov
and Verlinsky, 1998), but the parental source of haploidy could not
be identiﬁed in that report, because FISH technology was used.
Prior studies using FISH and G-banding have indicated that between
1.4 and 60.7% of blastocysts contain a degree of mosaicism between
cells of the same tissue (Clouston et al., 1997, 2002; Evsikov and Ver-
linsky, 1998; Magli et al., 2000; Derhaag et al., 2003; Baart et al., 2004;
Coonen et al., 2004; Munne ´ et al., 2005; Daphnis et al., 2008). Unlike
these prior studies, we made microarray measurements on embryo
fractions comprised of at least several cells. Mosaicism may have
occurred within these fractions. Mosaic embryos may appear
euploid if a mitotic error results in trisomy in a fraction of the
embryo and monosomy in the other fraction. However, we would
expect that conﬁdences would be lower in mosaic fractions. Given
that only 3 chromosomes out of 3013 were reported below 90% con-
ﬁdence, and no chromosomes were reported below 85% conﬁdence,
we ﬁnd it unlikely that mosaicism was common in these biopsies.
However, in light of reports of mosaicism in the literature, we
cannot exclude the possibility that mosaicism occurred occasionally
within the blastocyst fractions that we tested.
We found only two embryos that were discordant between TE and
ICM. This statistic is more or less in line with prior reports that used
CGH technology to compare TE and ICM (Clouston et al., 1997; Fra-
gouli et al., 2008). Both of the mosaic embryos in the current study
suffered from structural chromosome aberrations. Accordingly, the
only embryo that was mosaic between ICM and TE in one study
(Clouston et al., 1997) also suffered a structural chromosome aberra-
tion. Furthermore, structural chromosome aberrations have been pre-
viously associated with mosaic or chaotic karyotypes in blastocysts,
indicating a mitotic mechanism (Fragouli et al., 2008). Prior reports
have also indicated that mosaic tetraploidy is common in both clea-
vage stage embryos and blastocysts (Clouston et al., 1997, 2002;
Evsikov and Verlinsky, 1998; Veiga et al., 1999; Ruangvutilert et al.,
2000; Sandalinas et al., 2001). Our current study would not have
detected mosaic mitotic tetraploidy in the TE or ICM, because mito-
tically tetraploid cells are indistinguishable from two diploid cells using
microarray molecular karyotyping. Regardless, the clinical importance
of the diagnosis of tetraploidy is not clear (Clouston et al., 2002; Krieg
et al., 2009).
One of the families had two embryos that suffered from
12:q14.2-qter deletions in all of the fractions tested. One of the
embryos had the paternal copy of 12:q14.2-qter missing, whereas
the other embryo had the maternal copy of 12:q14.2-qter missing.
A karyotype is not available for this couple, but one would expect
that it would be exceptionally unlikely that familial balanced transloca-
tions or inversions would only co-occur in both parents and on the
same chromosome. This suggests that certain chromosomes have a
higher propensity to suffer from de novo breakage, as proposed in
prior studies (Wells and Delhanty, 2000; Fragouli et al., 2008).
Contemporary technologies, such as CGH, are being applied in a
clinical setting to obtain a molecular karyotype of TE biopsies
(MacArthur et al., 2008; Fragouli et al., 2009; Schoolcraft et al.,
2009; Sher et al., 2009). One study has reported doubling of preg-
nancy rates when using 24-chromosome screening (Sher et al.,
2009) and another study reported a 50% improvement in implantation
rates when using 24-chromosome screening (Schoolcraft et al., 2009).
Given the promising results of these prior studies, the microarray
technology described here is now being applied to TE biopsies in a
clinical setting at several IVF clinics in the USA and Europe.
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